qPULA Trading Management’s GSK GSK Stock Holding History

qPULA Trading Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,962	Closed	-$270K	–	64
2022 Q2	$270K	Sell	4,962 -13,318	-73%	-$735K	1%	47
2022 Q1	$995K	Buy	+18,280	New	+$993K	1.33%	11
2021 Q4	–	Sell	-11,257	Closed	-$538K	–	192
2021 Q3	$538K	Buy	+11,257	New	+$565K	0.84%	39
2021 Q1	–	Sell	-8,960	Closed	-$412K	–	144
2020 Q4	$412K	Buy	+8,960	New	+$412K	0.74%	49

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

qPULA Trading Management's GSK Position: Q3 2022 in Review

qPULA Trading Management sold out of GSK (GSK) in Q3 2022, closing a stake of 4,962 shares — an estimated $270K sold.

qPULA Trading Management first reported a position in GSK in Q4 2020 and held it in 4 quarters. The position peaked at $995K in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

qPULA Trading Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
qPULA Trading Management sold 4,962 GSK shares in Q3 2022, an estimated $270K.
qPULA Trading Management first reported a position in GSK in Q4 2020 and held it in 4 quarters.
qPULA Trading Management's GSK position peaked at $995K in Q1 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on qPULA Trading Management's 13F filing for Q3 2022, filed 10 Nov 2022.